Del Porto Flavia, di Gioia Cira, Tritapepe Luigi, Ferri Livia, Leopizzi Martina, Nofroni Italo, De Santis Vincenzo, Della Rocca Carlo, Mitterhofer Anna Paola, Bruno Guglielmo, Taurino Maurizio, Proietta Maria
Dipartimento di Medicina Clinica e Molecolare, Facoltà di Medicina e Psicologia, Ospedale Sant'Andrea, Rome, Italy.
Cardiology. 2014;127(2):123-9. doi: 10.1159/000355253. Epub 2013 Dec 3.
The aim of the study was to determine whether the release by macrophages of matrix metalloproteinase (MMP)-12 and vascular endothelial growth factor (VEGF) - leading to inflammation, matrix degradation and neoangiogenesis - represents an effective pathway that underlies aortic wall remodeling in Stanford type A acute aortic dissection (AAD).
Twenty-one consecutive patients with no genetic predisposition, with Stanford type A AAD were selected. In each patient, the levels of serum VEGF, MMP-12, serum interleukin (IL)-6, IL-8 and monocyte chemoattractant protein (MCP)-1 were evaluated using enzyme-linked immunosorbent assay. Ascending aortic specimens were collected for immunohistochemical identification of any presence of inflammatory infiltrate, VEGF and CD31 expression.
A significant increase in serum VEGF (p = 0.044), MMP-12 (p = 0.007), IL-6 (p = 0.0001), IL-8 (p = 0.0001) and MCP-1 (p = 0.0001) levels was observed in the AAD group compared to the control group. Furthermore, all AAD samples were positive for VEGF in the tunica media and showed vessel growth and immune-inflammatory infiltrate. A large number of cases (62.79%) showed inflammation at the edge of the dissection and approximately half (51.42%) showed neovessels growing at the edge of the dissection.
The results suggest that VEGF-mediated angiogenesis and matrix degradation play a role in AAD. Finally, we believe that MMP-12 should be considered a marker of AAD.
本研究旨在确定巨噬细胞释放基质金属蛋白酶(MMP)-12和血管内皮生长因子(VEGF)——导致炎症、基质降解和新生血管形成——是否代表了斯坦福A型急性主动脉夹层(AAD)主动脉壁重塑的有效途径。
选取21例无遗传易感性的斯坦福A型AAD连续患者。采用酶联免疫吸附测定法评估每位患者血清VEGF、MMP-12、血清白细胞介素(IL)-6、IL-8和单核细胞趋化蛋白(MCP)-1的水平。收集升主动脉标本进行免疫组织化学鉴定,以确定是否存在炎症浸润、VEGF和CD31表达。
与对照组相比,AAD组血清VEGF(p = 0.044)、MMP-12(p = 0.007)、IL-6(p = 0.0001)、IL-8(p = 0.0001)和MCP-1(p = 0.0001)水平显著升高。此外,所有AAD样本的中膜VEGF均呈阳性,并显示血管生长和免疫炎症浸润。大量病例(62.79%)在夹层边缘出现炎症,约一半(51.42%)在夹层边缘出现新生血管生长。
结果表明VEGF介导的血管生成和基质降解在AAD中起作用。最后,我们认为MMP-12应被视为AAD的一个标志物。